Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
about
Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models.Advances in native high-performance liquid chromatography and intact mass spectrometry for the characterization of biopharmaceutical products.Click-Chemistry-Mediated Rapid Microbubble Capture for Acute Thrombus Ultrasound Molecular Imaging.
P2860
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@en
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@nl
type
label
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@en
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@nl
prefLabel
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@en
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@nl
P2093
P2860
P50
P356
P1476
Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.
@en
P2093
Agnese Maggi
Christel Vangestel
Eduardo Ruivo
Jens Fissers
Jurgen Joossens
Sneha Chatterjee
P2860
P304
P356
10.1039/C6OB01411A
P577
2016-07-19T00:00:00Z